Author name: HAVEN Access

advocacy

Government Representatives that may help our initiative.

Why contact: Liberty‑focused, strong opponent of federal overreach, and previously defended kratom policy choices as constitutional issues.  Best message hook: Emphasize civil liberties, government restraint, and harm reduction. ⸻ Why contact: Chair of Senate Energy & Natural Resources, skeptical of overregulation, and has questioned FDA/DEA actions previously. Best message hook: Focus on protecting medical freedom and preventing unnecessary federal bans. ⸻ Why contact: Powerful Finance Committee member and vocal on medical alternatives and drug policy reform.  Best message hook: State how scheduling threatens patient access and innovation in natural therapies. ⸻ Why contact: One of few House members supportive of kratom rights, open to harm reduction approaches.Best message hook: Emphasize continuity: 7‑OH is a safer alternative many of his constituents rely on. ⸻ Why contact: On House Energy & Commerce (Health subcommittee), familiar with nuanced regulatory policy.Best message hook: Stress risk of bypassing science and oversight — direct legislative influence can demand transparency. 🇺🇸 SEN. RAND PAUL🔗 https://www.paul.senate.gov/connect/📞 202-224-4343🧠 Why: Liberty advocate who opposes federal overreach✏️ Tip: Mention his history standing against prohibition and for individual freedoms 🇺🇸 SEN. MIKE LEE🔗 https://www.lee.senate.gov/contact📞 202-224-5444🧠 Why: Regulatory skeptic; key role on oversight committees✏️ Tip: Highlight his focus on due process, limited government, and transparency 🇺🇸 SEN. RON WYDEN🔗 https://www.wyden.senate.gov/contact/email-ron📞 202-224-5244🧠 Why: Senior member on Senate Finance, influences health policy✏️ Tip: Frame it as a need for fair access to alternatives and science-based policy 🇺🇸 REP. MARK POCAN (WI constituents only)🔗 https://pocan.house.gov/address_authentication?form=/contact/contact-my-team📞 202-225-2906🧠 Why: Publicly supported kratom and harm reduction before✏️ Tip: Mention his past advocacy and ask him to oppose bans lacking human data 🇺🇸 REP. MORGAN GRIFFITH🔗 https://morgangriffith.house.gov/contact/contactform.htm📞 202-225-3861🧠 Why: Sits on House Energy & Commerce Health Subcommittee✏️ Tip: Emphasize the need for scientific evidence and measured regulation

advocacy

Contact these DEA offices to help stop or delay the scheduling of 7OH:

Contact these DEA offices to help stop or delay the scheduling of 7OH: ⸻ DEA HeadquartersPhone: (571) 362-8487Main Phone: (202) 307-1000Use for general questions about DEA processes. Ask for clear timelines and urge them to delay scheduling until thorough scientific review and public input can be fully considered. Emphasize the importance of harm reduction and the potential consequences of rushing the decision. ⸻ DEA Public AffairsEmail: DEA.Public.Affairs@dea.govPhone: (571) 776-2508Ask about public education plans on 7-OH and how the DEA will communicate the scheduling process. Urge transparency and encourage them to consider community concerns and harm reduction before proceeding. Request that scheduling be delayed to allow more open dialogue. ⸻ Office of Public Affairs, Community Outreach SectionPhone: (202) 307-7936Email: community.outreach@dea.govContact regarding community concerns and outreach related to 7-OH and kratom. Encourage them to raise public awareness about potential risks of scheduling and ask for a delay to gather more data and input. ⸻ Office of Diversion Control (Diversion Control Division)Phone: 202-307-7297Emails: ODLL@dea.gov, DPY@dea.govThis division regulates controlled substances to prevent illegal diversion. Since 7-OH scheduling would create a ban, ask how they plan to handle the likely rise of an illegal black market and associated public health risks. Urge them to delay scheduling until they have evaluated and prepared to mitigate these risks thoroughly. ⸻ Registration QuestionsEmail: DEA.Registration.Help@dea.govCurrently less relevant since 7-OH isn’t scheduled yet; focus on preventing scheduling before registration becomes an issue. If contacted, emphasize the need to halt or delay scheduling for more research. ⸻Press InquiriesEmail: DEAPress@dea.govPhone (voicemail): 571-776-2508 Media can use this to get official DEA statements. Encourage journalists covering the scheduling fight to highlight community concerns, the lack of toxicity data, and the need for delays to ensure safety and fairness. ⸻ How to help:@everyone can call or email these contacts with polite but firm messages urging them to reconsider or delay scheduling 7-OH. Emphasize: • Harm reduction benefits of 7-OH • Lack of evidence for toxicity or public emergency • Broad community support and scientific studies • Risks of creating illegal black markets and public health issues • The need for transparency and thorough review before scheduling

Scroll to Top